We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+29.74%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$60.7M
Cap. Flow
+$28.3M
Cap. Flow %
26.83%
Top 10 Hldgs %
81.35%
Holding
68
New
25
Increased
4
Reduced
9
Closed
9

Top Buys

Rank Stock Value
1
NSTG
NanoString Technologies, Inc.
NSTG
+$17.8M
2
BPMC
Blueprint Medicines
BPMC
+$14.8M
3
GNFT
Genfit
GNFT
+$9.23M
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$7.09M
5
EYPT icon
EyePoint Inc
EYPT
+$3.53M

Top Sells

Rank Stock Value
1
MNKD icon
MannKind Corp
MNKD
+$16.2M
2
SCPX
Scorpius Holdings, Inc.
SCPX
+$1.64M
3
IRD
Opus Genetics
IRD
+$1.44M
4
VLRX
VALERITAS HOLDINGS INC
VLRX
+$989K
5
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
+$585K

Sector Composition

Rank Sector Weight
1 Healthcare 68.47%
2 Communication Services 5.16%
3 Technology 1.99%
4 Consumer Discretionary 0.75%
5 Materials 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APOPW
51
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$1K ﹤0.01%
12,498
– –
APDNW
52
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$1K ﹤0.01%
31,407
– –
CYTXZ
53
DELISTED
Cytori Therapeutics Inc Series S Warrant
CYTXZ
$1K ﹤0.01%
259,200
– –
MYNDW
54
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$1K ﹤0.01%
13,700
– –
ALAR
55
Alarum Technologies
ALAR
$12.5M
– –
-58
Closed -$34K
CREG
56
DELISTED
Smart Powerr
CREG
– –
-232
Closed -$172K
SNOA icon
57
Sonoma Pharmaceuticals
SNOA
$5.26M
– –
-449
Closed -$58K
TNXP icon
58
Tonix Pharmaceuticals
TNXP
$152M
– –
0
– -$36K
IRD
59
Opus Genetics
IRD
$287M
– –
-32,247
Closed -$1.44M
WHWK
60
Whitehawk Therapeutics
WHWK
$181M
– –
-11,074
Closed -$282K
VBIV
61
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-12,197
Closed -$585K
AVGR
62
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
-49
Closed -$44K
SOLOW
63
DELISTED
Electrameccanica Vehicles Corp. Ltd. Warrants
SOLOW
– –
-75,300
Closed -$34K
NSPRZ
64
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$0 ﹤0.01%
48,000
– –
UUUU.WS
65
DELISTED
Energy Fuels Inc.
UUUU.WS
– –
-277,777
Closed –
1 2
3

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q1 2019 Portfolio in Review

As of Q1 2019, CVI Holdings held 68 positions worth $106M, up 135% from $44.9M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

CVI Holdings deployed $28.3M of net new capital in Q1 2019, opening 25 new positions and adding to 4 existing holdings. Its largest new stake was NanoString Technologies, Inc.: 774,068 shares worth $18.5M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 42% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was MannKind Corp, an estimated $16.2M trimmed.

  • CVI Holdings's largest Q1 2019 buy was NanoString Technologies, Inc.: 774,068 shares worth $18.5M.
  • CVI Holdings added most to Sio Gene Therapies Inc. Common Stock in Q1 2019, an estimated $7.09M increase.
  • CVI Holdings's biggest Q1 2019 reduction was MannKind Corp, cutting an estimated $16.2M.
  • CVI Holdings fully exited Opus Genetics in Q1 2019, selling an estimated $1.44M.
  • CVI Holdings's ten largest holdings make up 81% of its $106M portfolio in Q1 2019.
  • CVI Holdings opened 25 new positions and closed 9 in Q1 2019.
  • CVI Holdings's portfolio value rose 135% quarter-over-quarter to $106M.

Based on CVI Holdings's 13F filing for Q1 2019, filed 15 May 2019.